www.vet-webinar.com uses cookies to offer you the best possible service. Read more

Webinars & e-learning courses All webinars

Nursing the end-stage cancer patient 

Nursing the end-stage cancer patient 
Nursing the end-stage cancer patient 

As veterinary patients age, they are more susceptible to diseases and cancer. This webinar will cover the basic cancer biology, treatment options and palliative care. In addition, pain management, anti-inflammatory drugs, common medications and feeding guidelines as well as a quality-of-life scale will be discussed. The goal is to make the patient as comfortable as possible. Educating clients how to assess the quality of life and recognise pain is important, it is also a nurses’ role to be able to recognise those in patients. The journey is not easy, but it may be rewarding. Knowledge is the power to be able to help and improve the welfare and the quality of patient care. 

The Australian Veterinary Nurse and Technician (AVNAT) Regulatory Council has allocated (1) AVNAT CPD point to this continuing education activity. 

Recording from 28 September 2021

Speaker:

BVSCMomokoIto_image.jpg

Momoko Ito

VTS (Oncology)

Momoko is from Japan and moved to Brisbane in 2006. She completed a Bachelor of Veterinary Technology at the University of Queensland in 2011. She has worked in general practice before working at Brisbane Veterinary Specialist Centre. She started as a full-time rotating nurse at BVSC in 2011, then became BVSC's Primary Chemotherapy Nurse in 2013. Momoko also volunteered at the RSPCA Wildlife Hospital every Saturday for one year as well as taking casual shits at the BVECCS Emergency Centre.
In June 2018, Momoko passed the exam to become a Veterinary Technician Specialist (VTS) in Oncology accredited by the Academy of Internal Medicine Veterinary Technicians in the US. She is currently the first and the only VTS (Oncology) in Australia. Her daily goal is to give our patients the best attentions and care, and also to be the better communication bridge between owners and veterinarians to achieve a good quality of life in cancer patients. Her interest is not only limited to Oncology but also Internal Medicine and Feline Behaviour and Handling.
Momoko grew up with 4-6 cats. She admits being a crazy cat lady who also loves dogs. She enjoys yoga, indoor soccer and occasional hiking.

Booking information

Duration: 0:53 h
Speaker: Momoko Ito
from 1
57.60 US$
(inkl. tax)

You might also be interested in

tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice
Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
Details
webinar-pic 3x2.jpg
Stephanie Colthurst
0:51 h

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats
Tumors of the skin and subcutaneous tissues are the most common malignancies in dogs and cats accounting for over 30-40% of tumors in dogs and 29% in cats...
Details
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient
Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
Details
Back to overview
Webinars & e-learning courses